SYVA
Live / Registered — Registered (as of 09 Sept 2025)
What this means for you
Registered since 09 Sept 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98806088
- Registration number
- 7934420
- Mark type
- Stylized text
- Filed
- 17 Oct 2024
- Published for opposition
- 22 Jul 2025
- Registered
- 09 Sept 2025
- Attorney of record
- Andrew Chien
Goods and services
- Class 005 — Pharmaceuticals: Diagnostic test reagents for detecting drug abuse; diagnostic kits comprised of diagnostic test reagents for detecting drug abuse; diagnostic preparations for medical or veterinary purposes; diagnostic reagents for therapeutic drug monitoring purposes; diagnostic kits comprised of diagnostic reagents for therapeutic drug monitoring purposes; chemical preparations for for detecting drug abuse; chemical preparations for therapeutic drug monitoring purposes; medical diagnostic reagents for drug detection purposes; diagnostic reagents kits comprised of diagnostic reagents for drug detection purposes; immunodiagnostic agents for medical use
Owner
- Siemens Healthcare Diagnostics Inc., Tarrytown, NY, US
- Siemens Healthcare Diagnostics Inc., Tarrytown, NY, US
- Siemens Healthcare Diagnostics Inc., Tarrytown, NY, US
Prior registrations
Prosecution history
- 09 Sept 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 09 Sept 2025 — REGISTERED-PRINCIPAL REGISTER
- 22 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Jul 2025 — PUBLISHED FOR OPPOSITION
- 16 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Jun 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 24 May 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 24 May 2025 — FINAL REFUSAL E-MAILED
- 24 May 2025 — FINAL REFUSAL WRITTEN
- 21 Apr 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 21 Apr 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 21 Apr 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED